CBG, short for cannabigerol, is a non-intoxicating compound found in cannabis that serves as the chemical precursor to THC, CBD, and most other cannabinoids. It’s often called the “mother cannabinoid” because the cannabis plant produces it first, then converts it into the more familiar compounds as the plant matures. Most mature cannabis flower contains only 1 to 3% CBG by dry weight, which is why it’s less well known than THC or CBD despite playing a foundational role in the plant’s chemistry.
Why CBG Is Called the Mother Cannabinoid
Every major cannabinoid in cannabis starts life as cannabigerolic acid, or CBGA, the acidic form of CBG. Early in the plant’s growth cycle, specialized enzymes convert CBGA into the precursors of THC, CBD, and CBC (cannabichromene). One enzyme steers CBGA toward becoming THCA, which later becomes THC. Another enzyme converts it into CBDA, the precursor to CBD. A third enzyme produces CBCA, which becomes CBC.
These conversions happen while the plant is still alive and growing. The final step, turning those acidic precursors into the active cannabinoids people are familiar with, happens through heat exposure (like smoking or vaping) or slow degradation over time. Because CBGA is the shared starting material for all of these pathways, very little of it remains unconverted by the time the plant reaches full maturity. That’s why CBG levels in harvested cannabis are so low compared to THC or CBD.
How CBG Differs From CBD and THC
CBG does not get you high. In a double-blind, placebo-controlled human trial, participants reported no intoxicating effects from CBG and showed no cognitive or motor impairment. That puts it in the same non-intoxicating category as CBD, but the two compounds work through different mechanisms in the body.
CBD primarily interacts with serotonin receptors (specifically 5-HT1A), which is thought to underlie its calming and anti-seizure effects. CBG also interacts with serotonin receptors, but it acts on them differently: while CBD activates these receptors, CBG appears to block them. CBG also strongly activates a type of adrenaline receptor (alpha-2 adrenoceptors) that CBD does not significantly target. It may also interact with CB2 receptors, part of the body’s endocannabinoid system involved in immune function and inflammation.
These distinct receptor profiles mean CBG and CBD are not interchangeable, even though both are non-intoxicating. They may complement each other in products that combine multiple cannabinoids, but their individual effects on the body are fundamentally different.
Potential Health Benefits Under Investigation
CBG research is still largely in the animal and lab study phase, but the early results have drawn significant interest in several areas.
Gut Inflammation
In rodent models of colitis (a stand-in for inflammatory bowel diseases like Crohn’s and ulcerative colitis), CBG reduced intestinal inflammation, lowered tissue swelling, and normalized levels of key inflammatory markers. The effect appears to work partly through CB2 receptor activation, reducing the production of compounds that drive oxidative stress in the gut lining.
Neuroprotection
CBG showed strong neuroprotective effects in two different mouse models of Huntington’s disease, a degenerative brain condition. In mice exposed to a neurotoxin, CBG improved motor function, preserved brain cells in the striatum (the region most affected in Huntington’s), and reduced brain inflammation. In a genetic mouse model of the disease, CBG partially normalized the expression of several disease-related genes and modestly reduced the buildup of the abnormal protein that drives Huntington’s progression.
Antibacterial Activity
CBG has shown the ability to kill drug-resistant bacteria, including MRSA, by disrupting bacterial cell membranes. It is effective against both actively growing bacteria and mature biofilms, the sticky colonies that make infections particularly hard to treat. This property is shared with CBD and a few other cannabinoids, but CBG is consistently highlighted as one of the more potent options.
Other Areas
Preclinical research has also found that CBG reduces eye pressure (relevant to glaucoma), stimulates appetite, and shows antioxidant and anti-tumor activity in lab settings. None of these findings have been confirmed in human clinical trials yet.
Side Effects and Safety
The limited human data available paints a reassuring picture. In the placebo-controlled trial mentioned above, CBG produced no significant changes in dry eyes, dry mouth, sleepiness, appetite, or heart palpitations compared to placebo. Ratings on all of these measures changed less than one point from baseline throughout the experiment. The researchers concluded CBG was well tolerated and did not produce the adverse effects typically associated with THC.
That said, human research on CBG is still sparse. Five individuals in the screening phase of that same study reported having previously experienced a severe adverse reaction to CBG, though details were not elaborated. As with any supplement, individual responses vary, and the long-term safety profile remains unknown.
Why CBG Products Cost More
The economics of CBG come down to simple scarcity in the plant. Commercial cannabis flower typically contains CBGA at around 1% by dry weight. In one extraction analysis, a sample yielded 15.4 mg/g of CBD but only 0.452 mg/g of CBG, roughly 34 times less. Producing meaningful quantities of CBG requires either processing vastly more plant material or growing specially bred cultivars that have been developed to accumulate higher levels of CBGA (sometimes around 10% or more) instead of converting it into THC or CBD.
Harvesting timing also matters. Because CBGA converts into other cannabinoids as the plant matures, growers targeting CBG often harvest earlier in the flowering cycle, before those conversions are complete. This means sacrificing yield of other cannabinoids. The extraction equipment itself adds cost too, with large-scale systems running anywhere from $300,000 to $10 million depending on the technology. All of these factors make CBG isolate and CBG-rich products more expensive than their CBD equivalents, though prices have been dropping as more high-CBG cultivars reach the market.
How People Use CBG
CBG is available in many of the same formats as CBD: oils, tinctures, capsules, gummies, and flower from high-CBG hemp strains. Some products combine CBG with CBD or other cannabinoids based on the idea that cannabinoids work better together, sometimes called the entourage effect. Others offer CBG isolate for people who want the compound on its own.
Because CBG is derived from hemp (cannabis with less than 0.3% THC), it falls into the same legal gray area as CBD in the United States. The 2018 Farm Bill removed hemp from the controlled substances list, which effectively made hemp-derived cannabinoids like CBG legal at the federal level. Individual state laws vary, and the regulatory landscape continues to shift, so the rules in your area may differ.
Dosing is not well established. The human trial on anxiety and stress used a single dose, and there are no widely accepted guidelines for daily CBG supplementation. Most products on the market provide between 10 and 50 mg per serving, but optimal doses for specific effects have not been determined through clinical research.